(Q52905253)

9 May 2018

title

Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy. (English)

1 reference

9 May 2018

1 reference

T J Postma

1

1 reference

9 May 2018

J J Heimans

2

1 reference

9 May 2018

M J Muller

3

1 reference

9 May 2018

G J Ossenkoppele

4

1 reference

9 May 2018

J B Vermorken

5

1 reference

9 May 2018

N K Aaronson

6

1 reference

9 May 2018

publication date

1 July 1998

1 reference

9 May 2018

published in

Annals of Oncology

1 reference

9 May 2018

volume

9

1 reference

9 May 2018

issue

7

1 reference

9 May 2018

page(s)

739-744

1 reference

9 May 2018

Reporting results of cancer treatment

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

Grading of neurotoxicity in cancer therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

Comprehensive criteria for assessing therapy-induced toxicity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

Statistical evaluation of agreement between two methods for measuring a quantitative variable.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

The Equivalence of Weighted Kappa and the Intraclass Correlation Coefficient as Measures of Reliability

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

Nerve growth factor prevents toxic neuropathy in mice

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

Assessing the reliability of two toxicity scales: implications for interpreting toxicity data.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non-hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

Vincristine neuropathy. Clinical and electrophysiological observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008344507482

7 January 2021

Identifiers

DOI

10.1023/A:1008344507482

1 reference

9 May 2018

1 reference

9 May 2018